United States:
CMS Educational Event On New Part D Opioid Overutilization Policies
15 February 2019
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
On February 14, 2019, CMS is hosting an educational call on new opioid policies for Medicare drug plans.
The call will focus on improved safety alerts when opioid
prescriptions are dispensed at the pharmacy, and drug management
programs for individuals at-risk for misusing or abusing
"frequently abused drugs" (opioids and benzodiazepines).
The target audience for the call includes physicians, physician
assistants, nurses, nurse practitioners, dentists, case managers,
and other interested stakeholders. To register, visit the CMS website.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...